Overview

Adaptimmune is a leader in the development of T-cell therapies for the treatment of cancer. Adaptimmune has a robust clinical program and an exciting pipeline of new targets. At Adaptimmune, our team is driven by a core goal: That together we can change the way certain cancers are treated, and bring important new T-cell therapeutics to patients in need.

Based in the heart of Philadelphia, PA, Adaptimmune offers the opportunity to take part in pioneering the development of T cell therapy. The company has an inventive and collaborative culture, where employees are valued and inspired as well as rewarded for their ideas and contributions. The organization of research in Adaptimmune has created an environment where it is possible to make both individual and team contributions towards scientific excellence.

Our culture fostered trusting each other, our bravery in handling successes and failures, our ability to collaborate, and our honesty. It is through this that we find solutions to the most challenging issues we face in our fight against cancer.